In the last trading session, 58599.0 shares of the Orchestra BioMed Holdings Inc (NASDAQ:OBIO) were traded, and its beta was 0.52. Most recently the company’s share price was $5.28, and it changed around -$0.16 or -2.94% from the last close, which brings the market valuation of the company to $200.71M. OBIO currently trades at a discount to its 52-week high of $10.06, offering almost -90.53% off that amount. The share price’s 52-week low was $3.96, which indicates that the current value has risen by an impressive 25.0% since then. We note from Orchestra BioMed Holdings Inc’s average daily trading volume that its 10-day average is 0.11 million shares, with the 3-month average coming to 96.11K.
Orchestra BioMed Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.17. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended OBIO as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.
Orchestra BioMed Holdings Inc (NASDAQ:OBIO) trade information
Instantly OBIO has showed a red trend with a performance of -2.94% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.70 on recent trading dayincreased the stock’s daily price by 7.37%. The company’s shares are currently up 32.00% year-to-date, but still down -3.47% over the last five days. On the other hand, Orchestra BioMed Holdings Inc (NASDAQ:OBIO) is 3.73% up in the 30-day period. We can see from the shorts that 0.7 million shares have been sold at a short interest cover period of 9.88 day(s).
Orchestra BioMed Holdings Inc (OBIO) estimates and forecasts
Orchestra BioMed Holdings Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -34.25 percent over the past six months and at a -12.16% annual growth rate that is well below the industry average of 16.50%.
OBIO Dividends
Orchestra BioMed Holdings Inc’s next quarterly earnings report is expected to be released in February.
Orchestra BioMed Holdings Inc (NASDAQ:OBIO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 22.00% of Orchestra BioMed Holdings Inc shares, and 54.97% of them are in the hands of institutional investors. The stock currently has a share float of 70.47%.
